跳至主要内容
临床试验/CTRI/2024/08/071977
CTRI/2024/08/071977尚未招募不适用

Comparison of hemodynamic profile of 0.5% hyperbaric Levobupivacaine and 0.5% hyperbaric Bupivacaine in patients undergoing Lower Limb Arthroscopic Surgeries under spinal anaesthesia, a prospective randomized control study

Vikram C1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年8月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
To compare the hemodynamic effects between 0.5% Hyperbaric Bupivacaine and 0.5% Hyperbaric Levobupivacaine

研究概览

简要总结

Subarachnoid blockade is a principal technique in lower extremity surgical anesthesia. This study primarily aims to provide a comprehensive analysis of the differences in hemodynamic stability between 0.5% hyperbaric Levobupivacaine and 0.5% hyperbaric Bupivacaine. Secondarily study anaesthetic efficacy, onset of sensory and motor blockade, patient recovery and overall surgical outcomes in elective lower limb surgeries. All these results can help make Subarachnoid blockade safer and tailor the drug as per requirement.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • ASA Grade 1 and 2 Patients undergoing lower limb arthroscopic surgeries under spinal anaesthesia.

排除标准

  • Patients who are unwilling Known hypersensitivity to any of the test drug Any contraindication to spinal anaesthesia Cardiac arrythmias/ severe cardiac disease.

结局指标

主要结局

To compare the hemodynamic effects between 0.5% Hyperbaric Bupivacaine and 0.5% Hyperbaric Levobupivacaine

时间窗: Intraoperative hemodynamic parameters (BP, HR, and MAP) | will be assessed at 1 minute before (baseline) and 1, 2, 3, | and 5 minutes after the induction of spinal anesthesia. | Thereafter, measurements will be performed in 5-minute | intervals during the first 30 minutes of surgery and then | every 10 minutes until the end of the surgery.

次要结局

  • 1.Duration of analgesia(2.Sensory and motor block onset)

研究者

发起方
Vikram C
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Vikram C

Institute of Naval Medicine, INHS ASVINI

研究点 (1)

Loading locations...

相似试验